Clinical trial
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
NCT00140998 · Nemours Children's Clinic, Other · Completed
Key facts
| NCT number | NCT00140998 |
|---|---|
| Title | Estrogen Treatment (Oral vs. Patches) in Turner Syndrome |
| Official title | Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery |
| Lead sponsor | Nemours Children's Clinic, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Turner Syndrome, Hypogonadism, Premature Ovarian Failure |
| Intervention type | Drug |
| Interventions | 17 beta estradiol |
| Enrollment | 16 |
| Start date | Jan 1, 2001 |
| Completion | Jun 1, 2004 |
| First posted | Sep 1, 2005 |
| Last update posted | Nov 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: